Cu(2+)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Cu(2+) — no detected effect on incidence of cardiovascular disease (composite)
Evidence strength: moderate.FindingNull result“There were no significant differences between copper groups in the incidence of new cirrhosis (Log-Rank p = 0.734) or cardiovascular events (Log-Rank p = 0.747) during follow-up.”
Quoted verbatim from Hepatic Copper Accumulation Predicts Fibrosis Progression and Mortality in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).. - Study
- cohort
- Population
- Adults with biopsy-proven MASLD, high (>= 50 ug/g dry tissue) versus normal (< 50 ug/g) hepatic copper on liver biopsy; endogenous hepatic copper, nobody dosed
Hepatic Copper Accumulation Predicts Fibrosis Progression and Mortality in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).2025PMID:4101044910.3390/nu17182923Permalink
To cite this finding: https://catalystproject.ai/e/01M5MYEPGSG3DPKRXPSBXTTCKV